Evogene shares are trading higher after the company announced its subsidiary received a grant from the Israel Innovation Authority to advance its program to develop a technology for the delivery of Ag-biologicals to agriculture.
Portfolio Pulse from Benzinga Newsdesk
Evogene shares rose following the announcement that its subsidiary received a grant from the Israel Innovation Authority to develop technology for delivering Ag-biologicals to agriculture.
September 30, 2024 | 6:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evogene's stock price increased after its subsidiary was awarded a grant by the Israel Innovation Authority to develop Ag-biologicals delivery technology.
The grant from the Israel Innovation Authority is a positive development for Evogene, as it supports the advancement of their subsidiary's technology. This news likely boosts investor confidence, leading to a rise in Evogene's stock price.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90